Mutational and transcriptional landscape of pediatric BCP lymphoblastic lymphoma; the role of platelet-derived TGF-1 in immune thrombocytopenia; phase 3 trial of mavorixafor in WHIM syndrome
In this week's episode we’ll discuss the mutational and transcriptional landscape of pediatric BCP lymphoblastic leukemia; learn more about the role of platelet-derived TGF-β1 in immune thrombocytopenia; and discuss the findings from a phase 3 trial of mavorixafor in WHIM syndrome.
Featured Articles:
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia
Phase 3 randomized trial of mavorixafor, CXCR4 antagonist, in WHIM syndrome
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.